It's the leading cause of blindness in people over the age of 50 and in our Healthy Living report a brand new treatment for Macular Degeneration that some are calling a miracle.
Margie Puslipher suffers from Macular Degeneration and was on the verge of blindness. It terrified her to think she might lose her independence.
Margie found out she was a candidate for a clinical trial involving a new drug called Lucentis. She agreed to the treatments and in a short time went from near blindness to 20/ 20 vision. Just a week after the first treatment, her dramatic improvement came into focus while eating lunch with her daughter.
Macular Degeneration affects 40 percent of all Americans over the age of 50. It comes in two forms, wet and dry. It's the wet form that's most severe and up until now, all doctors could do was slow down the vision loss. Lucentis may change all that.
Dr. Roi Goodart, Rocky Mountain Retina Consultants says, that Lucentis is been the first drug they've had where people actually improved their vision as a result of the treatment.
Lucentis is injected into the eye and works by blocking the formation of blood vessels that cause wet macular degeneration.
In clinical trails it had few side effects and doctors say they're impressed with the results.
This drug works best at early onset, so if you have any sudden changes in your vision, see your eye doctor immediately. Lucentis is brand new but its FDA approved and covered by Medicare.
For more information:
Rocky Mountain Retina Consultants
440 South 700 East suite 200
Toll free 888-496-4400